Su1127 MYOSTATIN CONTRIBUTES TO ALTERATIONS IN METABOLIC PATHWAYS AND MUSCLE ATROPHY IN MASH AND HCC AND IS A PROMISING BIOMARKER WITH METABOLIC MARKER PKM2 FOR RISK STRATIFICATION OF HCC
Bhowmick K, Xiang X, Ohshiro K, Amdur R, Yang X, Wong L, Shetty K, Latham P, Lau L, Crandall K, Cifani P, Cacaj F, Mishra B, Dasarathy S, Wang X, Yu H, Wang Z, Krainer A, Satapathy S, Crawford J, Mishra L. Su1127 MYOSTATIN CONTRIBUTES TO ALTERATIONS IN METABOLIC PATHWAYS AND MUSCLE ATROPHY IN MASH AND HCC AND IS A PROMISING BIOMARKER WITH METABOLIC MARKER PKM2 FOR RISK STRATIFICATION OF HCC. Gastroenterology 2024, 166: s-666. DOI: 10.1016/s0016-5085(24)01982-6.Peer-Reviewed Original Research